Table 4.

Subjects with type 2 diabetes

Subjects	1	2	3	4	5	6	7	8	9	10	11
Baseline Glucose	117	173	323	321	113	110	254	261	137	386	457
Glucose after 1 month	51	187	137	135	133	106	–	186	118	334	138
Glucose after 6 months	–	164	167	158	–	107	97	–	143	116	77
HbA1c before	8.6	10	8.8	14.6	6	6.5	12.1	–	6.3	8.6	–
HbA1c after 1 month	–	–	5.2	7.5	–	–	–	11	6	6.7	–
HbA1c after 6 months	–	7.1	6.2	7.6	–	6.3	6	–	5.7	7.6	5.7
Treatment before	Glyburide 5 mg TID Metformin 500 mg TID	Metformin 500 mg TID Glyburide 5–5 – 2.5	Metformin / glyburide 500 mg/5 mg TID	Glyburide 5 mg BID Metformin 850 mg QD	Metformin 500 mg QD	Metformin 500 mg QD	Glyburide 5 mg TID Metformin 850 TID	Insulin Glargine 30 U QD Metformin 850 mg QD	Metformin / glyburide 500 mg/5 mg half dose TID	NPH 45–0-20 Lispro 10–10-2	Glyburide 5 mg TID Metformin 850 mg TID
Treatment after 6 months	Stayed the same	Metformin 500 mg TID Glyburide 5 mg TID	Metformin /glyburide 500 mg/5 mg BID	Stayed the same	–	Stayed the same	NPH insulin 25 U QD Metformin 850 mg TID	–	Stayed the same	NPH 25–0-20 Lispro 10–10-3	Suspended Metformin Glyburide 5 mg TID

HbA1c Glycated hemoglobin, TID three times a day, BID two times a day, QD once a day, NPH neutral protamine Hagedorn